|
|
|
|
|
07.11.25 - 18:01
|
ASP Isotopes Jumps After Investment By Trump′s Boys (ZeroHedge)
|
|
|
ASP Isotopes Jumps After Investment By Trump's Boys
One month ago we discussed why isotope-developer ASP Isotopes (ASPI) is emerging as one of the nascent "nuclear" plays to provide fuel for the AI energy renaissance. It appears that Trump's kids read what we wrote.
This morning, just before the open, ASP Isotopes (ASPI) announced a private placement for convertible notes of their advanced materials subsidiary Quantum Leap Energy (QLE), in which investors would be none other than the Trump boys.
Eric and Donald Jr participated in the private placement led by American Ventures LLC (a fund run by Dominari Holdings CEO Soo Yu which has done work with the Trumps before) and ASPI for over $60 million of convertible notes for QLE. The subsidiary is due to be spun out of ASPI by the end of the year. An update on official dates is expected to be provided in the earnings report coming up on November 18th.
Source
QLE is developing the technology for enriching select isotopes with lasers, said to be si...
|
|
|
|
|
|
|
15.10.25 - 00:36
|
The Banker Behind the Trump Family′s Quick Wall Street Wins (Bloomberg)
|
|
|
One of the newest tenants of Trump Tower in New York City is a startup investment bank called Dominari Holdings Inc. It's located only two stories below the headquarters of the Trump Organization — a proximity that Dominari's president, Kyle Wool, considers a point of pride. Wool spent years cultivating a relationship with the Trump family, and since last year's election he's emerged as a kind of financial fixer for the president's two eldest sons and a cadre of senior Trump Organization employees. Together they've struck a succession of lucrative deals. Bloomberg News Wealth Reporter Annie Massa and Bloomberg News Reporter Zach Mider join Bloomberg Businessweek Daily to discuss. They speak with Carol Massar and Isabelle Lee. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
12.09.25 - 20:48
|
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters (GlobeNewswire EN)
|
|
|
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced that Dominari Securities LLC, which acted as the lead underwriter for the Company's underwritten initial public offering (the “Offering” or the “IPO”), has exercised in full the over-allotment option the Company granted to the underwriters and purchased additional 562,500 shares of common stock of the Company at the IPO price of $4.00 per share....
|
|
|
|
|
|
|
|
|
|
|
|
|
22.08.25 - 15:19
|
Dominari Holdings Announces Record Date for Cash Dividend (PR Newswire)
|
|
|
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce that its board of directors has authorized a special cash dividend of, in the aggregate, approximately $5 million, or $0.22 per share. The dividend is expected to be payable on or around......
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
